Mualliflar

  • Шамсутдинов М.М., Отамурадов Ф.А., Вахидов А.Ш., Шамсутдинова М.И.

##semicolon##

зонулин, фекальный кальпротектин, язвенный колит, диагностический маркер

##submission.citations##

Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep. 2019 Jul 23; 21 (8):40. doi: 10.1007/s11894-019-0705-6. PMID: 313 38613.

Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 Jan;91(1): 151-75. doi: 10.1152/physrev.000 03.2008. PMID: 21248165.

Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016 Oct 21;4(4): e1251384. doi: 10.1080/21688370.2016.1251384. PMID: 2812392 7; PMCID: PMC5214347.

Farquhar MG, Palade GE. Junctional complexes in various epithelia. J Cell Biol. 1963 May; 17(2):375-412. doi: 10.1083/jcb.17.2.375. PMID: 13 944428; PMCID: PMC2106201.

Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21. doi: 10.10 38/nrgastro.2016.169. Epub 2016 Nov 16. PMID: 27 848962; PMCID: PMC5554468.

Fasano, A. (2020). All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res 9, F1000 Faculty Rev–69. doi: 10.12688/f1000research.20510.1

Gargari, G., Mantegazza, G., Taverniti, V., Del Bo’, C., Bernardi, S., Andres Lacueva, C., et al. (2021). Bacterial DNAemia is associated with serum zonulin levels in older subjects. Sci. Rep. 11, 11054. doi: 10.1038/s41598-021-90476-0

Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S., et al. (2009). Identifification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc. Natl. Acad. Sci. U.S.A. 106, 16799–16804. doi: 10.1073/pnas.0906773106

Lacombe LAC, Matiollo C, Rosa JSD, Felisberto M, Dalmarco EM, Schiavon LL. Factors associated with circulating zonulin in inflammatory bowel disease. Arq Gastroenterol. 2022 Apr-Jun;59(2):238-243. doi: 10.1590/S0004-2803.202202000-43. PM ID: 35830035.

Vanuytsel T, Vermeire S, Cleynen I. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers. 2013 Dec 1;1(5):e27321. doi: 10.4161/tisb.27321. Epub 2013 Dec 10. PMID: 24868498; PMCID: PMC3943850.

Caviglia GP, Dughera F, Ribaldone DG, Rosso C, Abate ML, Pellicano R, Bresso F, Smedile A, Saracco GM, Astegiano M. Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva Med. 2019 Apr;110(2):95-100. doi: 10.23736/ S0026-4806.18.05787-7. Epub 2018 Aug 28. PMID: 30160088.

Schoultz I, KEITA ÅV. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells. 2020; 9:1909.

Vilela EG, Torres HOG, Ferrari MLA, Lima AS, Cunha AS. Gut permeability to lactulose and mannitol differs in treated Crohn’s disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008; 41:1105-9.

Halme L, Turunen U, Tuominen J, Fors-strom T, Turpeinen U. Comparison of iohexol and lactulose-mannitol test as markers of disease activity in patients with inflammatory bowel disease. Scand J Clin Lab Invest. 2000; 60:695-701.